Clinical Observation of Warm Needling Combined With and Electroacupuncture Therapy on Ovulatory Dysfunction

NCT05874518 | Completed

• 1 other identifier: LiuzhouMCHH
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

To observe the effect of warm needling combined with electroacupuncture on the ovulation promotion rate and pregnancy rate in luteinized unruptured follicle syndrome (LUFS).

Conditions

Warm Needling; Electroacupuncture; Ovulation Dysfunction

Outcome Measures

Primary Outcomes (5)

• Ultrasound characteristics of ovulation

  Monitoring follicular intima thickness

  About 10 days on average until ≥18mm follicle disappears or 20mm follicle volume decreases

• vaginal B-ultrasound to monitor follicles (size and discharge) and endometrial thickness on the fifth day of menstruation

  vaginal B-ultrasound to monitor follicles (size and discharge) and endometrial thickness on the fifth day of menstruation

  the endometrium of ≥8mm on the fifth day of menstruation

• Use vaginal B-ultrasound to monitor follicles (size and discharge) and endometrial thickness on the fifth day of menstruation

  When the follicle size reached 18mm and Chorionic gonadotrophin was injected

  48 hours after chorionic gonadotropin injection

• Pregnancy judgment

  Pregnancy was determined by detecting serum HCG (human chorionic gonadotropin) 14 days after ovulation

  14 days after ovulation

• Pregnancy judgment

  At about 50 days of pregnancy, pregnancy sac or fetal heart beat through vaginal B ultrasound

  about 50 days of pregnancy

Study Arms (2)

Experimental group

EXPERIMENTAL

Ask the patient to empty the bladder, and take supine position. Take guanyuan, zhongji, bilateral Tianshu, zigong, guilai, sanyinjiao, Taixi, zusanli, hegu points. Select 0.3mm×40mm fine needles. After conventional disinfection, the needle is 0.5-1 inch deep. Then the 1.5 cm moxa cones were inserted into the tail of the needle of the bilateral sanyinjioa and zusnli points for moxibustion. At the same time, electroacupuncture therapy was used. Select the density wave and set the time for 25 minutes. Generally, the patient feels comfortable as moderate, so that the patient feel acid, distension, heat or local muscles for rhythmic contraction. After treatment, first reduce the power to zero value, turn off the power supply, then remove the electrode clip from the needle handle, and pull out the fine needle stabbed into the tissue. Treatment begins on the 5th day of the menstrual cycle, qd (once a day), usually for 6-8 consecutive days, and continuing to the day of ovulation.

Other: warm needling combined with electroacupuncture

Control group

ACTIVE COMPARATOR

Treatment was started on day 5 of the menstrual cycle. Letrozole tablets were given at 2.5mg (Jiangsu Hengrui Pharmaceutical Co., Ltd., H19991001, 2.5mg per tablet), po (oral), qd, for 5-7 consecutive days. When the diameter of follicles reaches 18mm, Chorionic gonadotrophin is given at 5000u (Lizhu Group Lizhu Pharmaceutical Factory, Chinese medicine H44020668, 5000u per branch), with intramuscular injection, qd, to promote follicle discharge. Patients were also instructed to have sexual intercourse on the same day and on day 2.

Drug: The treatment with letrozole tablets was started on the fifth day of the menstrual cycle

Interventions

warm needling combined with electroacupuncture OTHER

Treatment begins on the 5th day of the menstrual cycle, qd (once a day), usually for 6-8 consecutive days, and continuing to the day of ovulation.

Experimental group

The treatment with letrozole tablets was started on the fifth day of the menstrual cycle DRUG

Letrozole tablets were given at 2.5mg (Jiangsu Hengrui Pharmaceutical Co., Ltd., H19991001, 2.5mg per tablet), po (oral), qd, for 5-7 consecutive days. When the diameter of follicles reaches 18mm, Chorionic gonadotrophin is given at 5000u (Lizhu Group Lizhu Pharmaceutical Factory, Chinese medicine H44020668, 5000u per branch), with intramuscular injection, qd, to promote follicle discharge. Patients were also instructed to have sexual intercourse on the same day and on day 2.

Control group

Eligibility Criteria

• Age: 23 Years - 48 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Infertility diagnosis criteria refer to the "Obstetrics and Gynecology" \[10\]: Infertility refers to the patient fails to conceive a pregnancy with normal sexual life and without contraception for 1 year. In primary infertility, pregnancy has never occurred. In secondary infertility, patients have previously conceived, but are unable to conceive again without contraception for 1 year.
• The standard for ovulation infertility is formulated according to the first series of Guiding Principles for Clinical Research of New Chinese Medicine: Basal body temperature was continuously recorded for single phase for more than 3 months; Vaginal detached cell smear examination showed no significant periodic changes; Cervical mucus crystallization examination showed no periodic changes, and ellipsoid; There was no typical secretory period change in endometrial examination on 6 days before menstruation; a series of B-ultrasound monitoring showed no ovulation signs; Blood and urinary progesterone levels were lower than those in the luteal phase. Patients who met two of the above 6 items could be diagnosed with anovulation

You may not qualify if:

• Those who have any serious adverse reactions during the treatment process and cannot continue the treatment
• Failing to follow the treatment plan and receiving other treatment
• Patients who quit the treatment process by themselves, or who have an incomplete course of treatment, will have a negative effect on the curative effect

Sponsors & Collaborators

• Liuzhou Maternity and Child Healthcare Hospital: lead

Study Sites (1)

Fanghua Yang

Liuchow, Guangxi, 545001, China

Location

MeSH Terms

Interventions

Electroacupuncture; Letrozole

Intervention Hierarchy (Ancestors)

Combined Modality Therapy; Therapeutics; Acupuncture Therapy; Complementary Therapies; Electric Stimulation Therapy; Physical Therapy Modalities; Rehabilitation; Transcutaneous Electric Nerve Stimulation; Analgesia; Anesthesia and Analgesia; Anesthesia; Nitriles; Organic Chemicals; Triazoles; Azoles; Heterocyclic Compounds, 1-Ring; Heterocyclic Compounds

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director

Study Record Dates

• First Submitted: April 11, 2023
• First Posted: May 25, 2023
• Study Start: December 1, 2021
• Primary Completion: April 30, 2022
• Study Completion: April 30, 2022
• Last Updated: May 25, 2023

Record last verified: 2023-05

Locations

CN (1)